SON and familial pancreatic carcinoma: The in vitro suppressive effect of siRNA targeting SON on proliferation was reanalyzed in detail by using MIA PaCa2; PCI-35, a pancreatic cancer cell line with an aggressive phenotype; and HPDE, an immortalized normal human pancreatic duct epithelial cell line [7,11-13].